Highwire Restrains Synaptic Growth by Attenuating a MAP Kinase Signal  by Collins, Catherine A. et al.
Neuron 51, 57–69, July 6, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.neuron.2006.05.026Highwire Restrains Synaptic Growth
by Attenuating a MAP Kinase SignalCatherine A. Collins,1 Yogesh P. Wairkar,1
Sylvia L. Johnson,1 and Aaron DiAntonio1,*
1Department of Molecular Biology and Pharmacology
Washington University School of Medicine
Washington University
St. Louis, Missouri 63110
Summary
Highwire is an extremely large, evolutionarily con-
served E3 ubiquitin ligase that negatively regulates
synaptic growth at the Drosophila NMJ. Highwire has
been proposed to restrain synaptic growth by downre-
gulating a synaptogenic signal. Here we identify such
a downstream signaling pathway. A screen for sup-
pressors of the highwire synaptic overgrowth pheno-
type yielded mutations in wallenda, a MAP kinase
kinase kinase (MAPKKK) homologous to vertebrate
DLK and LZK.wallenda is both necessary for highwire
synaptic overgrowth and sufficient to promote synap-
tic overgrowth, and synaptic levels of Wallenda pro-
tein are controlled by Highwire and ubiquitin hydro-
lases. highwire synaptic overgrowth requires the
MAP kinase JNK and the transcription factor Fos.
These results suggest that Highwire controls struc-
tural plasticity of the synapse by regulating gene
expression through a MAP kinase signaling pathway.
In addition to controlling synaptic growth, Highwire
promotes synaptic function through a separate path-
way that does not require wallenda.
Introduction
The growth of new synaptic contacts shapes the initial
development and subsequent refinement of neural cir-
cuits. Genetic studies have identifiedhighwireas a highly
conserved presynaptic regulator of synapse growth and
morphology. In Drosophila, loss of highwire causes dra-
matic synaptic overgrowth of the neuromuscular junc-
tion (NMJ) (Wan et al., 2000). In C. elegans, mutations
in the homolog rpm-1 cause defects in the morphology,
spacing, and number of presynaptic active zones
(Schaefer et al., 2000; Zhen et al., 2000). Mutations in
the zebrafish homolog esromdisrupt retinotectal projec-
tions (D’Souza et al., 2005), and deficiencies that remove
the mouse homologphr1and neighboring genes result in
altered NMJ development (Burgess et al., 2004).
Highwire and its homologs are enormous proteins,
ranging from 418 kDa in worms to 564 kDa in flies, and
all share a series of domains that likely perform distinct
biochemical activities. These include an N-terminal Ran
GTP exchange factor-like domain that can inhibit adeny-
late cyclase (Pierre et al., 2004), two PHR repeats of un-
known function, a domain shown to bind the myc onco-
gene (Guo et al., 1998), and a C-terminal RING finger that
can function as an E3 ubiquitin ligase. The molecular
*Correspondence: dianton@molecool.wustl.edufunction for each domain during synaptic growth is
thus far unknown; however, the prevailing model for
Highwire function focuses on its E3 ubiquitin ligase
activity. The C. elegans homolog rpm-1 interacts with
an SCF ubiquitin ligase complex (Liao et al., 2004), and
in both C. elegans and zebrafish the isolated RING do-
main can promote ubiquitination in vitro (D’Souza
et al., 2005; Nakata et al., 2005). In Drosophila, mutation
of the C-terminal RING finger abolishes highwire func-
tion (Wu et al., 2005). In addition, overexpression of
ubiquitin hydrolases, which antagonize ubiquitination
by removing ubiquitin from targeted proteins, promotes
synaptic overgrowth and enhances the highwire pheno-
type (DiAntonio et al., 2001). These results support a
model in which Highwire restrains synaptic growth by
downregulating levels of a signaling protein that pro-
motes synaptic growth.
What is the target of Highwire regulation? In Drosoph-
ila, Highwire has been proposed to regulate a TGF-b sig-
naling pathway through an interaction with co-SMAD
Medea (McCabe et al., 2004). However, in C. elegans,
the homolog rpm-1 regulates a p38 MAP kinase signal-
ing pathway (Nakata et al., 2005) and may also regulate
the tyrosine kinase ALK (Liao et al., 2004). Other candi-
date signaling pathways include cAMP metabolism in
cultured neurons and rat spinal cord (Pierre et al.,
2004), tuberous sclerosis complex (TSC) signaling in
cultured neurons and the fly eye (D’Souza et al., 2005;
Murthy et al., 2004), myc activity in cultured cells (Guo
et al., 1998), and pteridine biosynthesis in zebrafish (Le
Guyader et al., 2005). While Highwire may interact with
all of these varied pathways, it is not known which path-
way or pathways are essential for controlling synaptic
growth.
Our unbiased approach to this question was to con-
duct a genetic screen in Drosophila for mutations that
rescue the highwire synaptic overgrowth phenotype.
The model for Highwire function predicts that the levels
of a synaptogenic signaling protein would be increased
in a highwire mutant. Therefore, genetically reducing the
activity of such a protein should suppress the highwire
synaptic overgrowth phenotype. In a genetic screen
for such suppressors, we identified mutations in a single
gene that we have named wallenda, which encodes
a MAP kinase kinase kinase (MAPKKK) homologous to
the vertebrate dual leucine zipper-bearing kinases DLK
and LZK. Wallenda behaves as expected for a down-
stream target of Highwire. Both loss of highwire and
overexpression of ubiquitin hydrolases cause dramatic
increases in the level of Wallenda protein at synapses.
wallenda is absolutely required for highwire-dependent
synaptic overgrowth, and overexpression of wallenda is
sufficient to cause synaptic overgrowth. Downstream of
Wallenda, we find that the MAP kinase JNK and the tran-
scription factor Fos are also essential for highwire syn-
aptic overgrowth. Hence, Highwire controls synaptic
growth by regulating a MAP kinase signal and its tran-
scriptional output. The C. elegans Wallenda homolog
DLK-1 is also required for the synaptic phenotypes of
rpm-1 mutants (Nakata et al., 2005). This evolutionary
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MAPKKK is a fundamental function for this large neuro-
nal E3 ligase.
Results
A Genetic Screen for Mutations that Suppress the
highwire Synaptic Overgrowth Phenotype
At theDrosophilaNMJ, mutations in highwire cause dra-
matic synaptic overgrowth (Wan et al., 2000; Wu et al.,
2005). This implies that Highwire normally functions to
downregulate a pathway that mediates synaptic growth;
in its absence, this downstream pathway is overactive. A
prediction from this model is that the synaptic over-
growth could be suppressed by decreasing the activity
of this downstream pathway. To find potential compo-
nents of this pathway, we conducted a genetic screen
for mutations that can dominantly suppress the highwire
phenotype. Such a screen should identify genes whose
dosage is important for synaptic overgrowth. To con-
duct a large-scale screen, we took advantage of the ob-
servation that combining loss-of-function mutations in
highwire with overexpression of the ubiquitin hydrolase
fat facets (faf) is lethal (DiAntonio et al., 2001). This le-
thality could arise from the overactivity of a downstream
target normally regulated by ubiquitination. If so, then
mutating this hypothesized downstream target should
rescue lethality.
For the screen, flies carrying an upstream-activating
sequence (UAS) promoter upstream of fat facets were
chemically mutagenized and mated to highwire;elav-
Gal4 virgins. Since highwire is on the X chromosome,
all male offspring from this cross die because they are
both mutant for highwire and overexpress fat facets in
neurons. We screened over 20,000 mutagenized second
and third chromosomes for suppression of lethality and
found eighteen suppressors. Sixteen of these suppres-
sors disrupt the fat facets gene, which was expected,
since overexpression of nonfunctional fat facets is not
lethal in combination with highwire (DiAntonio et al.,
2001). The two suppressor mutations that did not map
to fat facets were candidate suppressors of highwire.
Genuine suppressors of highwire should not only sup-
press lethality, but should also suppress the cellular phe-
notype of synaptic overgrowth. Indeed, both mutations
dominantly suppress the highwire synaptic morphology
phenotype and, as transheterozygotes, completely sup-
press this phenotype (described in more detail below
and in Figure 1). Both mutations map to a single locus
on chromosome 3, and are phenocopied by deficiencies
that delete this region (76B4–76D5). The mutations are
therefore loss-of-function alleles of a single gene whose
function is essential for the highwire synaptic over-
growth phenotype. We name this suppressor wallenda
after the Flying Wallendas, an acrobat troupe famous
for their world record stunts on the circus highwire.
wallenda Mutations Completely Suppress the
highwire Synaptic Overgrowth Phenotype
The ability of wallenda mutations to suppress the
highwire synaptic morphology phenotype was charac-
terized in detail (Figures 1A–1I) at the NMJ of muscle 4,
which is formed from a single motoneuron, but similar
results are observed at all glutamatergic type I NMJs(Figures 1A–1C, lower panels). Mutations in highwire
cause dramatic synaptic overgrowth: a 4-fold increase
in the number of boutons (Figure 1E) and synaptic
branches (Figure 1F) and a 2-fold increase in total syn-
aptic area (Figure 1G). The highwire mutant phenotype
also causes a 66% reduction in bouton size (Figure 1H)
and a 70% reduction in the average intensity (Figure 1I)
and a 50% reduction in total intensity (data not shown) of
staining for synaptic vesicle proteins. For our analysis,
we use DVGLUT as a representative synaptic vesicle
marker, but similar effects are observed for synaptotag-
min (data not shown). All of the above parameters of the
highwire mutant phenotype are suppressed by muta-
tions in wallenda (Figures 1E–1I). Removing one copy
of wallenda suppresses the highwire phenotype for
each of these parameters by approximately 50% (p <
0.0001 for all parameters). Removing both copies of
wallenda confers complete suppression. The highwire;
wallenda double mutant (hiwND8;wnd1/wnd2) is not sig-
nificantly different from wild-type (p > 0.9 for all param-
eters). Therefore, the wallenda gene is essential for the
highwire synaptic overgrowth phenotype.
The allele of highwire used in Figure 1 (hiwND8) con-
tains a nonsense mutation in the N-terminal portion the
protein (Wan et al., 2000). However, some full-length
Highwire protein can be detected in this mutant due to
read-through of the premature stop codon (Wu et al.,
2005). To test whether suppression requires residual
highwire activity, we generated deletions that remove ei-
ther the N-terminal or C-terminal halves of the gene (Wu
et al., 2005). Both hiwDN and hiwDC can be suppressed
bywallenda similarly to hiwND8 (see Figure S1 in the Sup-
plemental Data). These results rule out the possibility
that wallenda functions as an upstream regulator of
highwire, and instead support the model that wallenda
functions downstream as an effector of the highwire
synaptic overgrowth phenotype. In the absence of high-
wire, this downstream pathway is overactive. This path-
way requires wallenda and is sensitive to its dose.
Comparison to Suppression by wit Mutants
It has been previously observed that mutations in the
BMP/TGF-b signaling pathway can suppress highwire
synaptic overgrowth, so we wished to compare this sup-
pression to suppression by wallenda. Figure 1D shows
suppression by mutations in the type II receptor wishful
thinking (witA12/witB11). Additional alleles of wit that are
genetic nulls are shown in Figure S2. Several differences
are of note. First, mutation of wit and other TGF-b path-
way components cause a very strong reduction in syn-
aptic growth (Aberle et al., 2002; Marques et al., 2002)
in genetic backgrounds that are either wild-type or mu-
tant for highwire (McCabe et al., 2004). When highwire is
wild-type, mutation of wit causes a dramatic reduction
in bouton number (64%), branching (80%), and synaptic
area (64%). In contrast, wallenda mutants show no re-
duction in synaptic growth in an otherwise wild-type
background (p > 0.9 compared to wild-type for all param-
eters). Second, TGF-b mutants do not suppress the re-
duced bouton size or synaptic vesicle protein intensity
phenotypes of highwire nearly as well as they suppress
the bouton number phenotype of highwire (McCabe
et al., 2004; Figures 1D, 1H, and 1I, and Figure S2). In con-
trast,wallendamutations suppress all parameters of the
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59Figure 1. Mutations in wallenda Suppress Synaptic Overgrowth
(A–D) and (J–K) NMJ synapses at muscle 4 (upper panels) and muscles 7, 6, 13 and 12 (lower panels), stained with the neuronal membrane marker
HRP (red) and synaptic vesicle marker DVGLUT (green). Scale bar, 25 mm. (A) wild-type (Canton S), (B) hiwND8, (C) hiwND8;wnd1/wnd2, (D) hiwND8;
witA12/witB11. (E–I) Quantitation of suppression of the highwire synaptic morphology phenotype. Averages for (E) number of boutons, (F) number
of branches, (G) synaptic area (mm2), (H) bouton size (mm2), and (I) average intensity of staining for DVGLUT were measured for muscle 4 of third-
instar larvae for the following genotypes: wild-type (Canton S), wnd (wnd1/wnd2), hiw (hiwND8), hiw;wnd/+ (hiwND8;wnd1/+), hiw;wnd
(hiwND8;wnd1/wnd2), wit (witA12/witB11), and hiw;wit (hiwND8;witA12/witB11). n > 18 for all genotypes, all parameters. (J) The synaptic overgrowth
phenotype caused by overexpression of fat facets (O/E faf: elav-Gal4/EP(3)381). (K) Suppression of fat facets induced synaptic overgrowth
by mutations in wallenda (O/E faf; wnd: elav-Gal4, wnd2/wnd1, EP(3)381). (L) Quantitation of suppression of fat facets induced overgrowth by
wallenda: changes in bouton number at NMJ muscle 4. Error bars = SEM.
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60Figure 2. wallenda Does Not Suppress the
highwire Defect in Synaptic Transmission
(A) Representative traces of evoked and
spontaneous neurotransmitter release re-
corded from wild-type (Canton S), hiw
(hiwND8), wnd (wnd1/wnd2), and hiw;wnd
(hiwND8;wnd1/wnd2) larvae. Calibration: 20
ms, 5 mV for evoked release; 200 ms, 2 mV
for spontaneous release.
(B–D) For the same genotypes, the mean EJP
amplitude (B), mEJP amplitude (C), and quan-
tal content (D) are plotted. n > 11 cells for
each genotype. In (C) the mEJP amplitude
of hiw;wnd is not significantly different from
wild-type (p > 0.9), and (*) is significantly
increased compared to hiw (p < 0.0005),
demonstrating that wallenda suppresses the
highwire defect in quantal size. In (D), the
quantal content of hiw;wnd is not significantly
different than hiw (p > 0.9), demonstrating
that wallenda does suppress the highwire
defect in evoked release. Error bars = SEM.highwire morphology phenotype completely. These dif-
ferences suggest that wallenda and TGF-b mutants
may suppress highwire through different mechanisms.
Consistent with this, no dominant genetic interactions
were observed between wallenda and mutations in wit
or the co-SMAD medea.
wallenda Suppresses Synaptic Overgrowth Caused
by Overexpression of fat facets
The genetic interactions between loss-of-function muta-
tions in the ubiquitin ligasehighwireand gain-of-function
mutations in the ubiquitin hydrolase fat facets suggest
that both mutations may influence the same signaling
pathway (DiAntonio et al., 2001). To test this hypothesis
we assessed whether wallenda can suppress fat fac-
ets-induced synaptic overgrowth. Neuronal overexpres-
sion of fat facets, like loss-of-function highwire, leads to
an increased number of synaptic boutons and branches
and an increased synaptic span (Figure 1J, left panels).
wallenda mutants suppress this phenotype (Figure 1K,
p < 0.0005). Therefore, wallenda is required for the over-
growth caused by both overexpression of a ubiquitin
hydrolase and loss of a ubiquitin ligase. wallenda thus
behaves genetically like a candidate substrate for ubiq-
uitination that could mediate synaptic overgrowth.
wallenda Does Not Suppress the highwire Defect
in Synaptic Function
highwire mutants have defects in synaptic function as
well as synaptic morphology. Since wallenda mutants
can suppress the morphological defects of highwire,
we tested whether wallenda mutants can also suppress
the synaptic transmission defects of highwire. highwire
mutants show both reduced quantal size (response to
a single vesicle) and reduced quantal content (numberof vesicles released by the nerve) (Figure 2, and see
Wan et al., 2000; Wu et al., 2005). wallenda mutants
alone have normal synaptic function, allowing us to
ask whether they could confer suppression to the high-
wire mutant phenotype. wallenda mutations do sup-
press the highwire defect in quantal size: both the ampli-
tude and frequency of spontaneous miniature events in
the highwire; wallenda double mutant are similar to wild-
type (p > 0.9). In contrast, the evoked potentials of the
highwire; wallenda double mutant are only modestly in-
creased, and this is due entirely to the increased quantal
size. The quantal content, calculated as the excitatory
junction potential (EJP) amplitude divided by the minia-
ture EJP (mEJP) amplitude, remains the same between
highwire and highwire; wallenda (p > 0.9). Therefore,
wallenda does not suppress the primary defect in high-
wire synaptic function, the reduced number of vesicles
released by the nerve. While the quantal size phenotype
of highwire may be secondary to the synaptic morphol-
ogy phenotype, the defect in quantal content cannot
be secondary to morphology. Therefore, highwire regu-
lates synaptic physiology through a distinct molecular
pathway that does not require wallenda.
wallenda is a Conserved MAPKKK
The genetic results described above suggest that wal-
lenda is a downstream target of highwire that functions
to promote synaptic growth. Using meiotic recombina-
tion and deficiency mapping, wallenda was mapped to
76B4–76D5 on the third chromosome. This location
was refined by male recombination mapping (Chen
et al., 1998) to a 20 kb region at 76B9. Four annotated
genes reside within this region, including the predicted
kinase CG8789. Sequencing of both wallenda alleles re-
vealed mutations in CG8789: wnd1 has a mutation in a
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61Figure 3. Wallenda is a Conserved MAPKKK
(A) Schematic of Wallenda protein (CG8789 in
Drosophila) and homologs DLK and LZK in
human, and DLK-1 in C. elegans, with loca-
tion of wallenda mutations and the peptide
used to make a-Wallenda (WndA1) anti-
bodies. Dark gray boxes denote the kinase
domain; Zs and gray boxes denote leucine
zippers. The shaded region denotes the re-
gion of highest similarity among species.
(B) Cladogram representing the degree of
similarity among Wallenda homologs in dif-
ferent species. The first column of numbers
reports the percent of amino acid identity
within the shaded region to Drosophila Wal-
lenda protein. The second column reports
the overall amino acid identity to Drosophila
Wallenda protein.conserved residue in the kinase domain, and wnd2 has
a mutation in the stop codon that adds an extra 104
amino acid tail to the protein (Figure 3). We serendipi-
tously found a third allele ofwallenda,wnd3, in ahighwire
mutant line (hiwPF253) that showed heterogeneity in the
synaptic overgrowth phenotype. We mapped the source
of this heterogeneity to a suppressor mutation at the
wallenda locus. This mutation of spontaneous origin
behaves exactly like a new loss-of-function mutation in
wallenda: wnd3 can fully suppress the highwire synaptic
overgrowth phenotype (Figure S1). Sequencing re-
vealed that wnd3 contains a roo transposon insertion
in the middle of the CG8789.
CG8789 belongs to the family of mixed lineage kinases
that function as MAPKKKs for JNK and p38 signaling
pathways. Its closest vertebrate homologs are the dual
leucine zipper-bearing kinases DLK and LZK (Figure 3)
(Holzman et al., 1994; Sakuma et al., 1997). Its similarity
to these vertebrate kinases (63% identity in the kinase
domain) is much greater than to its closest Drosophila
relative, the mixed lineage kinase slipper (which shares
only 29% identity in the kinase domain). Vertebrate
DLK is expressed in neurons and has been observed to
localize to synapses (Hirai et al., 2005; Mata et al.,
1996). The C. elegans homolog DLK-1 was identified
as a suppressor of the highwire homolog rpm-1 (Nakata
et al., 2005). Hence, the regulation of this kinase is con-
served between C. elegans and Drosophila.
Endogenous Wallenda Protein Localizes to
Synapses and Is Regulated by Highwire
If wallenda functions downstream of highwire, it should
be expressed in neurons where highwire function is re-
quired. In situ hybridization experiments in embryos de-
tect wallenda transcript in the CNS at stage 13 and later,
stages when axon guidance and synapse development
take place (data not shown). To determine where Wal-
lenda protein localizes, we raised polyclonal antisera
in rabbits (WndA1) to a peptide near the C terminus (de-
noted in Figure 3). In embryos stage 13 and older, the a-
Wallenda antibodies stain the neurite- and synapse-rich
neuropil in the CNS. wnd3 mutants show no neuropil
staining, demonstrating the specificity of the antibodies
(Figures 4A and 4C).If wallenda is directly downstream of highwire then
Highwire should regulate Wallenda protein levels. In em-
bryos there is no significant difference in a-Wallenda
staining between wild-type and highwire mutants (Fig-
ures 4A and 4C). In contrast, loss of highwire dramati-
cally alters Wallenda staining in ventral nerve cords of
third-instar larvae (Figures 4B and 4C). In wild-type
larvae Wallenda is barely detectable in the neuropil, al-
though there is slightly more (16%) staining than in the
wnd3 mutant (p < 0.01). In highwire mutant larvae, Wal-
lenda staining in the neuropil is dramatically increased.
In addition, immunoblots of total protein extracts from
dissected larval nerve cords demonstrate that mutation
of highwire causes an increase in the total levels of Wal-
lenda protein (2.5-fold, p < 0.01, Figures 4D and 4E). The
difference in Wallenda levels between embryos and lar-
vae, and the differential effect of highwire mutations
during these two stages, indicates that Highwire func-
tions to control Wallenda primarily in larvae. This is con-
sistent with the finding that Highwire functions through-
out larval development to control synaptic growth (Wu
et al., 2005). Interestingly, this is the developmental pe-
riod when the NMJ grows most dramatically (Schuster
et al., 1996).
The increase in Wallenda levels when the ubiquitin li-
gase Highwire is mutated suggests that Wallenda is reg-
ulated by ubiquitination. To test this model, we assayed
the effects of overexpressing the ubiquitin hydrolases
fat facets and yeast UBP2 on Wallenda. Neuronal over-
expression of either hydrolase leads to dramatic in-
creases in Wallenda staining in the neuropil, consistent
with a role for ubiquitination in the downregulation of
Wallenda (Figures 4C and 4D). Since overexpression of
either of these ubiquitin hydrolases causes synaptic
overgrowth (DiAntonio et al., 2001; Figure 1), there is a
remarkable correlation between increased Wallenda
levels and synaptic growth.
Does Wallenda protein localize to the NMJ? Antibody
staining in the CNS neuropil is consistent with a synaptic
localization of Wallenda. Wallenda staining at the NMJ
follows a similar trend to the neuropil staining. It is not
reproducibly detectable in wild-type larvae, but when
highwire is mutant or when the ubiquitin hydrolase
UBP2 is driven in neurons, we detect Wallenda in distinct
Neuron
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(A) Staining for endogenous Wallenda in CNS neuropil of stage 16 embryos for wild-type (Canton S), hiwDN, and wnd3 genotypes. Upper panels
show Wallenda staining alone (using the rabbit WndA1 antibody), and lower panels show costaining of Wallenda (green) with neuronal marker
BP102 (red). Scale bar, 25 mm.
(B) Staining for endogenous Wallenda in CNS neuropil in ventral nerve cords of third-instar larvae for wild-type, highwire mutant (hiwDN), high-
wire; wallenda double mutant (hiwDN;wnd3), overexpressed fat facets [elav-Gal4, EP(3)381] and overexpressed UBP2 (elav-Gal4/UAS-UBP2)
genotypes. Upper panels show Wallenda staining alone, and lower panels show costaining of Wallenda (green) with the synaptic marker
NC82 (red). Scale bar, 25 mm.
(C) Quantitation of average Wallenda staining in the neuropil of stage 16 embryos and third-instar larvae for the genotypes shown in (A) and (B);
n = 6, 10, 21, 15, 16, 8, and 5, respectively. The Wallenda intensity was measured for each genotype and the background intensity measured for
wnd3 mutant embryos or larvae was subtracted (see Experimental Procedures). In embryos, Wallenda staining is not significantly different
between wild-type and highwire mutant embryos (p > 0.9). In wild-type larvae, Wallenda staining is barely detectable above background levels
(a 16% increase, p < 0.01). Mutations in highwire and overexpression of fat facets or UBP2 all cause a significant increase in Wallenda staining
over the levels in wild-type (p < 0.005).
(D) Representative Western blots of extracts from larval brains and ventral nerve cords (VNC) probed for Wallenda and b-tubulin. The left panels
show whole-brain extracts (which include the brain lobes and ventral nerve cords) from wild-type and wnd3 mutant larvae, demonstrating the
specificity of the Wallenda antibodies. The right panel shows extracts from ventral nerve cords of wild-type and hiwDN larvae.
(E) Quantitation of Wallenda levels from Western blots, normalized to b-tubulin. Loss of highwire causes a 2.5-fold increase in the level of
Wallenda protein in ventral nerve cord extracts (p < 0.005, n = 4).
(F) Representative staining for endogenous Wallenda at the NMJ for wild-type (Canton S), highwire mutant (hiwDN), highwire; wallenda double
mutant (hiwDN;wnd3), and overexpressed UBP2 (elav-Gal4/UAS-UBP2) genotypes. Wallenda is not detectable in wild-type larvae, but
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63Figure 5. Overexpression of Wallenda Pro-
motes Synaptic Overgrowth
(A) NMJ synapses at muscle 4 of larvae that
are wild-type (DVGLUT-Gal4/+) or (B) over-
express wallenda (UAS-wnd/+; DVGLUT-
Gal4/+). Third-instar larvae are stained with
the neuronal membrane marker HRP (red)
and synaptic vesicle marker DVGLUT (green).
Scale bar, 25 mm.
(C–E) Quantitation of (C) average number
of boutons, (D) bouton size (mm2), and (E)
DVGLUT intensity for larvae that are wild-
type (DVGLUT-Gal4/+), larvae that over-
express wallenda cDNA (UAS-wnd/+;
DVGLUT-Gal4/+), and larvae that overex-
press wallenda cDNA mutated in the kinase
domain (UAS-wndKD/+; DVGLUT-Gal4/+).
n > 18 for all genotypes and all parameters.
Neuronal overexpression of wallenda pheno-
copies highwire mutants for all measured pa-
rameters (p < 0.0001). Mutation of the kinase
domain abolishes all wallenda gain-of-func-
tion phenotypes (p > 0.9 between wild-type
and O/E wndKD). Error bars = SEM.puncta within boutons (Figure 4F). Therefore, highwire
affects the levels of Wallenda protein at the NMJ.
Highwire Can also Influence the Levels
of Transgenic Wallenda Protein
The effect of highwire and fat facets on Wallenda stain-
ing is likely due to direct regulation of the Wallenda pro-
tein. However, it is formally possible that these mutants
affect Wallenda indirectly by regulating wallenda gene
expression. To test this possibility we expressed wal-
lenda from a UAS-wnd transgene using the heterolo-
gous yeast UAS/Gal4 expression system (Brand and
Perrimon, 1993). However, in a highwire mutant back-
ground, expression of wallenda causes embryonic le-
thality. This observation supports the hypothesis that
Highwire normally functions to counteract the activity
of Wallenda. To circumvent this lethality we mutated
a conserved residue (K188) in the kinase domain of the
transgene to generate kinase-disrupted UAS-wndKD.
Mutation of the analogous lysine disrupts the kinase ac-
tivity of mouse DLK (Mata et al., 1996; Xu et al., 2001).
This transgene can be overexpressed robustly without
causing death or other observable phenotypes. The ki-
nase-mutated protein localizes to the NMJ (Figure 4E)
and to CNS neuropil and cell bodies (data not shown).
We could then ask whether removal of highwire affects
the level of this transgenic protein. Indeed, loss of high-
wire results in a greater than 6-fold increase in levels of
transgenic Wallenda at the NMJ (Figures 4E and 4F).
Wallenda staining in the CNS neuropil is also dramati-
cally increased (data not shown). These results suggest
that Highwire downregulates Wallenda protein. A similar
result was observed with transgenic DLK-1 in C. elegans
(Nakata et al., 2005).Wallenda is Sufficient to Confer
Synaptic Overgrowth
The data thus far support the model that loss of highwire
results in an overabundance of Wallenda protein, which
causes synaptic overgrowth. To test whether overex-
pression of Wallenda is sufficient to cause synaptic
overgrowth, we used a UAS-wnd cDNA transgene to
overexpress Wallenda in motoneurons (see Experimen-
tal Procedures). Expression of the wallenda transgene
results in synaptic overgrowth that is reminiscent of
the highwire loss-of-function phenotype (Figure 5). All
the defects previously measured for the highwire loss-
of-function phenotype (in Figure 1) are reproduced by
overexpression of Wallenda: bouton number (Figure 5C)
and branching (data not shown, p << 0.001) are in-
creased by over 4-fold, synaptic area is increased 2.5-
fold (p < 0.005), bouton size (Figure 5D) and the average
intensity of synaptic vesicle markers are reduced 4-fold
(Figure 5E). Since expression of UAS-wndKD gives no
phenotype, the effects on synaptic growth are likely to
require the kinase activity of Wallenda. Expression of
UAS-wnd in postsynaptic muscles also results in no
observable defects (data not shown). Hence, neuronal
overexpression of the Wallenda kinase is sufficient to
induce synaptic overgrowth.
Synaptic Overgrowth Requires JNK Signaling
Since Wallenda requires a wild-type kinase domain to
promote synaptic growth, it likely functions through a
MAP kinase signaling pathway. Wallenda belongs to a
family of MAPKKKs known to activate p38 and JNK sig-
naling (Gallo and Johnson, 2002). InDrosophila there are
two p38 genes, p38a and p38b, and a single JNK gene,
basket (bsk). We tested whether either p38 or Bsk,reproducibly detected in puncta at NMJs of highwire mutant larvae. Upper panels show Wallenda staining alone (using the rabbit WndA1 anti-
body), and lower panels show costaining of Wallenda (green) with the neuronal marker HRP (red). Scale bar, 5 mm.
(G) Staining for overexpressed transgenic Wallenda at the NMJ of third-instar larvae. Wallenda is overexpressed with the UAS-wndKD transgene
in a control (left: BG380-Gal4; UAS-wndKD) or highwiremutant background (right: hiwND8, BG380-Gal4; UAS-wndKD). As in (F), upper panels show
Wallenda staining alone, and lower panels show costaining of Wallenda (green) with the neuronal marker HRP (red). Scale bar, 25 mm.
(H) Quantiation of staining for transgenic Wallenda from UAS-wndKD for the genotypes shown in (G) and normalized to the average staining for
control larvae (BG380-Gal4; UAS-wndKD). n = 17 and 18.
Error bars = SEM.
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64Figure 6. highwire Synaptic Overgrowth Re-
quires JNK Signaling
(A–F) Dominant-negative transgenes for JNK,
but not p38, suppress the highwire and wal-
lenda gain-of-function synaptic overgrowth
phenotypes. NMJ synapses at muscle 4 for
(A) wild-type (BG380-Gal4/+), (B) hiw (hiwND8,
BG380-Gal4), (C) hiw + p38DN (hiwND8,
BG380-Gal4/hiwDN, UAS-p38bDN; Dp38a),
(D) hiw + JNKDN (hiwND8, BG380-Gal4;
UAS-BskDN/+), (E) O/E wnd (BG380-Gal4/+;
UAS-wnd/+), and (F) O/E wnd + JNKDN
(BG380-Gal4/+; UAS-wnd/+; UAS-BskDN/+).
Third-instar larvae are stained with the neuro-
nal membrane marker HRP (red) and synaptic
vesicle marker DVGLUT (green). Scale bar,
25 mm.
(G) Quantitation of the average number of
synaptic boutons for the following geno-
types: wild-type (BG380-Gal4/+), p38
(BG380-Gal4/UAS-p38bDN; Dp38a), JNKDN
(BG380-Gal4; UAS-BskDN/+), and as shown
in (A)–(F), hiw, hiw + JNKDN, O/E wnd, and
O/E wnd + JNKDN. n = 46, 16, 56, 36, 29, 60,
26, and 30, respectively. *p < 0.0001, **p <
0.0001. hiw; p38 is not significantly different
from hiw (p > 0.9). Error bars = SEM.like Wallenda, is required for highwire-dependent
synaptic overgrowth. To inhibit both genes for p38 in
Drosophila, we combined a deletion for p38a (Craig
et al., 2004) with a dominant-negative transgene for
p38b (UAS-p38bDN) that contains a mutation in the ki-
nase domain and inhibits p38 function (Adachi-Yamada
et al., 1999). To inhibit bsk without disrupting its role in
early embryonic development, we used a UAS-bskDN
transgene (Weber et al., 2000; denoted as JNKDN in Fig-
ure 6) that has a nonfunctional kinase domain. Both
transgenes were expressed in a wild-type or highwire
mutant background in postmitotic neurons using the
BG380-Gal4 driver. Simultaneous inhibition of p38a
and p38b does not suppress the highwire synaptic phe-
notype (Figure 6C). In contrast, inhibiting JNK signaling
by expressing bskDN (JNKDN) suppresses the highwire
phenotype (Figure 6D), reducing the number of synaptic
boutons (Figure 6G) and branches and increasing bou-
ton size and the intensity of synaptic vesicle markers
(data not shown). The wallenda gain-of-function pheno-
type is similarly suppressed by bskDN (Figures 6E–6G).
Hence, synaptic overgrowth in a highwire mutant re-
quires JNK signaling.
Synaptic Overgrowth Requires the Fos
Transcription Factor
JNK signaling affects many cellular processes, often by
regulating transcription factor activity that leads to
changes in gene expression. A common downstream
effector of JNK-mediated changes in gene expression
is the AP-1 complex of Fos and Jun transcription fac-tors, which can regulate synaptic growth at the Dro-
sophila NMJ (Sanyal et al., 2003). To investigate whether
Drosophila Fos or Jun (known as D-fos and D-jun, re-
spectively) are required for highwire-dependent synap-
tic overgrowth, we inhibited each by expressing domi-
nant-negative transgenes that contain the DNA binding
and dimerization domains of Fos and Jun but lack the
transcriptional activation domains (Eresh et al., 1997).
Expression of these dominant-negative transgenes in
postmitotic neurons allowed us to circumvent early em-
bryonic requirements for D-fos and D-jun (Kockel et al.,
1997).
When FosDN and JunDN are neuronally expressed in
a wild-type background, there is a modest trend toward
inhibition of synaptic growth, consistent with previous
observations (Sanyal et al., 2003). When expressed in
a highwire mutant background, the FosDN transgene
confers dramatic suppression of the highwire synaptic
phenotype (Figures 7D and 7G), reducing bouton num-
ber and branching (42%) and increasing the intensity
of staining for synaptic vesicle markers at the synapse
(2.2-fold, p < 0.0001). The reduction in highwire-depen-
dent synaptic overgrowth is much greater than the
reduction of growth in a wild-type background. In con-
trast, JunDN does not suppress the highwire phenotype
(Figures 7C and 7G). This suggests the existence of a
pathway that is separate from AP-1, consistent with
previous results in Drosophila demonstrating that D-
Fos can act independently of D-Jun (Riese et al., 1997;
Riesgo-Escovar and Hafen, 1997). The requirement for
D-Fos in highwire synaptic overgrowth suggests that
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65Figure 7. highwire Synaptic Overgrowth Re-
quires Fos
(A–F) The Fos dominant-negative transgene
Fbz suppresses the highwire and wallenda
gain-of-function synaptic overgrowth pheno-
types. NMJ synapses at muscle 4 for (A) wild-
type (BG380-Gal4/+), (B) hiw (hiwND8, BG380-
Gal4), (C) hiw + JunDN (hiwND8, BG380-Gal4;
UAS-JunDN/+), (D) hiw + FosDN (hiwND8,
BG380-Gal4; UAS-FosDN/+), (E) O/E wnd
(BG380-Gal4/+; UAS-Wnd/+), and (F) O/E
wnd + FosDN (BG380-Gal4/+; UAS-Wnd/+;
UAS-FosDN/+). Third-instar larvae are stained
with the neuronal membrane marker HRP
(red) and synaptic vesicle marker DVGLUT
(green). Scale bar, 25 mm.
(G) Quantitation of average number of synap-
tic boutons for the following genotypes: wild-
type (BG380-Gal4), JunDN (BG380-Gal4;
UAS-JunDN/+), FosDN (BG380-Gal4; UAS-
FosDN/+), and as shown in (A)–(F) hiw, hiw +
JunDN, hiw + FosDN, O/E wnd, and O/E wnd
+ FosDN. n > 10 for all genotypes. *p <
0.0001, **p < 0.0001. hiw + JunDN is not sig-
nificantly different from hiw (p > 0.9). Error
bars = SEM.the highwire phenotype involves changes in gene ex-
pression rather than exclusively local changes to the
synapse.
If FosDN acts downstream of Wallenda to inhibit syn-
aptic overgrowth, it should also suppress the synaptic
overgrowth caused by overexpressing wallenda. In-
deed, when FosDN was coexpressed with UAS-wnd
in neurons, FosDN could suppress the wallenda gain-
of-function phenotype (Figures 7E–7G), leading to
a 38% reduction in synaptic bouton number, a 52% re-
duction in synaptic branching, a 54% increase in bouton
size, and a 3.8-fold increase in the intensity of staining of
synaptic vesicle markers (p < 0.01 and n > 13 for all pa-
rameters). This is consistent with D-Fos acting down-
stream of Wallenda to promote synaptic growth. There-
fore, the synaptic overgrowth phenotypes caused by
loss of highwire and by overexpression of wallenda are
similar in their requirements for the transcription factor
D-Fos.
Discussion
Highwire is an extremely large, evolutionarily conserved
protein that restrains synaptic growth at the Drosophila
NMJ (Wan et al., 2000). Current models suggest that
Highwire functions as an E3 ubiquitin ligase to downre-
gulate a signaling pathway that promotes synaptic
growth (D’Souza et al., 2005; DiAntonio et al., 2001;
Liao et al., 2004; Nakata et al., 2005; Wu et al., 2005).
Here we identify a MAPKKK, Wallenda, whose proteinlevels are controlled by Highwire and the activity of ubiq-
uitin hydrolases. We demonstrate that Wallenda is both
necessary for highwire-dependent synaptic overgrowth
and sufficient to promote synaptic growth. Downstream
of Wallenda, the MAP kinase JNK and transcription fac-
tor Fos are required for highwire-dependent synaptic
overgrowth. We propose that Highwire restrains synap-
tic growth by downregulating the MAPKKK Wallenda,
thereby inhibiting signaling through the JNK MAP kinase
and the Fos transcription factor. In the absence of high-
wire, this signaling pathway is overactive, leading to
changes in gene expression that result in excessive syn-
aptic growth.
A Conserved Function for Highwire Is to
Regulate the MAPKKK Wallenda
The regulation of the MAPKKK Wallenda is conserved
from Drosophila to C. elegans (Nakata et al., 2005). In
both organisms, the synaptic phenotype of highwire/
rpm-1 requires the Wallenda/DLK-1 MAPKKK and
downstream MAPK signaling. However, the down-
stream MAPK pathways diverge: in C. elegans, the
rpm-1 phenotype requires a p38 MAP kinase (Nakata
et al., 2005), while the highwire phenotype requires
JNK signaling. This suggests that regulation of the spe-
cific MAPKKK Wallenda/DLK-1, rather than a particular
downstream MAP kinase pathway, is a fundamental
activity of Highwire and its orthologs.
Since Highwire functions as an E3 ubiquitin ligase to
restrain synaptic growth (Wu et al., 2005), Wallenda is
Neuron
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downstream of highwire and is essential for the synaptic
overgrowth in highwire mutants. Second, increasing
the levels of Wallenda by overexpression is sufficient
to confer synaptic overgrowth. Third, Highwire regulates
Wallenda protein levels through a posttranscriptional
and most likely posttranslational mechanism. Each of
the points above is conserved from Drosophila to
C. elegans (Nakata et al., 2005). Fourth, Wallenda protein
levels are regulated by ubiquitination in vivo, since inhib-
iting ubiquitination by overexpressing ubiquitin hydro-
lases increases the levels of Wallenda protein. Fifth,
the RING domain of the C. elegans homolog rpm-1 can
interact with the Wallenda homolog DLK-1 and stimulate
its ubiquitination when both are overexpressed in 293T
cells (Nakata et al., 2005).
Targeting a MAPKKK, which sits at the top of a MAP
kinase signaling pathway, is an attractive mechanism
for spatially and temporally controlling a synaptogenic
signal without affecting downstream components
shared by multiple MAPK signaling cascades. Restrain-
ing MAP kinase signaling is essential for controlling di-
verse cellular processes, including cell proliferation, dif-
ferentiation, and apoptosis. The targeting of MAPKKKs
by specific ubiquitin ligases may be a powerful and gen-
eral mechanism for regulating MAP kinase signals (Laine
and Ronai, 2005; Yamashita et al., 2005).
While Wallenda is an essential mediator of the high-
wire mutant phenotypes in both Drosophila and C. ele-
gans, an endogenous synaptic function for Wallenda
has not yet been identified in either organism: the wal-
lenda mutants have surprisingly normal synapse mor-
phology and function. This may be due to another path-
way that compensates for the loss of wallenda function.
Such redundancy would obscure the role of wallenda. A
second possibility is that wallenda functions in an as-
pect of synaptic growth that is not detected or required
under laboratory culture conditions. For instance, wal-
lenda could promote synaptic growth as part of a struc-
tural plasticity program that responds to unknown expe-
rience-dependent stimuli. A third possibility is that
Wallenda does not normally function at synapses, but
its upregulation in highwire mutants causes a neomor-
phic phenotype. In this scenario, the regulation of Wal-
lenda by Highwire is required for normal synaptic devel-
opment, but endogenous Wallenda would not itself
regulate the synapse. The neuropil and synaptic locali-
zation of Wallenda and the vertebrate homolog DLK
(Hirai et al., 2005; Mata et al., 1996) is, however, consis-
tent with a synaptic function.
As an activator of MAP kinase signaling, Wallenda and
its homologs might also control other processes beyond
the synapse. Functional studies in vertebrates suggest
that DLK and JNK signaling regulate neuronal migration
and axon outgrowth in the developing cortex (Hirai et al.,
2002). Outside of the nervous system, DLK influences
keratinocyte differentiation (Robitaille et al., 2005), and
LZK is highly expressed in the pancreas, liver, and pla-
centa (Sakuma et al., 1997). In Drosophila, we find that
wallenda mutants are female sterile. We predict that
the regulation of DLK and LZK is conserved from worms
and flies to vertebrates. Therefore, the vertebrate homo-
logs of Highwire might regulate some of these neuronal
and/or extraneuronal developmental processes.Multiple Functions for Highwire
Highwire is a large, multidomain protein that, in addition
to acting as an E3 ubiquitin ligase, has been shown to in-
hibit adenylate cyclase, influence TSC signaling and
pteridine biosynthesis, and interact with the myc onco-
gene and the co-SMAD Medea (Guo et al., 1998; Le
Guyader et al., 2005; McCabe et al., 2004; Murthy
et al., 2004; Pierre et al., 2004). It is remarkable that
throughout millions of years of evolution, members of
the Highwire family have retained an exceptionally large
size and complex domain structure. An attractive expla-
nation for this conservation is that this molecule could
serve as an intersection point for multiple signaling
pathways, integrating MAP kinase and other signals
during neural development.
The ubiquitin ligase activity alone could be responsi-
ble for regulating more than one downstream target. In-
teractions with components of TSC (tuberin/hamartin)
and TGF-b signaling pathways suggest that Highwire
might target either or both of these pathways (McCabe
et al., 2004; Murthy et al., 2004). The model that Highwire
regulates TGF-b signaling through interaction with the
co-SMAD Medea has received considerable attention.
Since the TGF-b pathway regulates synaptic growth at
the NMJ, it has been proposed that synaptic overgrowth
of highwire mutants is caused by overactivity of this
pathway (McCabe et al., 2004). Null alleles of wit, which
completely disrupt TGF-b signaling at the NMJ (Aberle
et al., 2002; Marques et al., 2002), can partially suppress
the highwire phenotypes: they partially suppress the in-
crease in bouton number, but show little or no suppres-
sion of the reduced bouton size and the reduced inten-
sity for synaptic vesicle markers (Figure 1, Figure S2;
McCabe et al., 2004). This partial suppression of high-
wire by wit is consistent with the model that overactive
TGF-b signaling contributes to the highwire phenotype.
However, the data are also consistent with the alternate
model that TGF-b signaling and Highwire act in parallel
pathways. An assay for the activity of TGF-b signaling
is to stain for phosphorylated-MAD (phospho-MAD),
the major transducer of BMP signals in Drosophila, in
motoneuron nuclei. We detected no change in the levels
of phospho-MAD staining in highwire mutants com-
pared to wild-type (Figure S2). This assay is sensitive
to changes in pathway activity—neuronal expression
of the constitutively active type I receptor thick veins
leads to a 40% increase in phospho-MAD staining (Fig-
ure S2). Interestingly, this increase in TGF-b signaling
does not lead to excess synaptic growth. Combining
a highwire mutant with expression of constitutively ac-
tive thick veins does cause excess growth (McCabe
et al., 2004), but it does not lead to any further increase
in phospho-MAD staining (Figure S2). These data are
consistent with highwire and TGF-b signaling acting in
parallel pathways.
Whether or not Highwire regulates TGF-b signaling, it
is likely to target an additional pathway. Highwire not
only restrains synaptic growth, but also promotes syn-
aptic function. Synaptic function requires the ubiquitin
ligase activity of Highwire (Wu et al., 2005) and is sensi-
tive to the levels of the ubiquitin hydrolase fat facets
(DiAntonio et al., 2001). Here we demonstrate that this
regulation of neurotransmitter release does not require
Wallenda. Therefore, Highwire must regulate at least
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67two distinct molecular pathways. If Wallenda is a sub-
strate whose downregulation is essential for restraining
synaptic growth, there is likely another substrate for
Highwire whose downregulation promotes neurotrans-
mitter release.
Signaling Downstream of Wallenda
Highwire regulates synaptic growth via the MAPKKK
Wallenda. Downstream of Wallenda, the JNK MAP ki-
nase and Fos transcription factor are required for the
highwire synaptic morphology phenotype. Therefore,
Highwire attenuates a JNK signaling pathway that pre-
sumably controls gene expression to regulate synaptic
growth. Previous studies have implicated JNK-depen-
dent transcriptional control in activity-dependent
growth of theDrosophila NMJ (Sanyal et al., 2003). How-
ever, this previously described pathway is probably dis-
tinct from the JNK signal that is controlled by Highwire
and activated by Wallenda. The previously described
role for JNK requires AP-1, a heterodimer of Fos and
Jun transcription factors; inhibiting either D-Fos or D-
Jun disrupts this pathway. In contrast, highwire-induced
overgrowth requires D-Fos, but not D-Jun. The Wal-
lenda pathway could therefore involve a homodimer of
D-Fos or another transcription factor that interacts
with Fos. Such D-Jun-independent functions of D-Fos
have been described previously in Drosophila (Riese
et al., 1997; Riesgo-Escovar and Hafen, 1997). The dif-
ferential requirement for transcription factors suggests
that the output of Wallenda signaling cannot simply be
activation of JNK, but instead activation of JNK in a par-
ticular spatial or temporal context, such as in the pres-
ence of cofactors that influence downstream signaling.
In addition to transcription factors, substrates for ac-
tivated JNK include components of the cytoskeleton.
Because the NMJ is distant from the motoneuron nu-
cleus, and because vertebrate DLK colocalizes with tu-
bulin in axonal regions of the brain (Hirai et al., 2005),
we initially expected that the Highwire/Wallenda/JNK
pathway would influence synaptic morphology through
local action upon the synaptic cytoskeleton. Instead,
we identified a requirement for a transcription factor
and presumably changes in gene expression. However,
this does not exclude an interaction with the cytoskele-
ton or local changes at the synapse. It is possible
that Highwire regulates the Wallenda signal in the cell
body. However, the observation that Wallenda accumu-
lates in the synapse-rich neuropil and at the NMJ when
Highwire is absent suggests that Wallenda could be-
come activated at the synapse. This would imply the
need for a mechanism to transport the activated JNK
signal back to the nucleus. In addition, cell-wide
changes in gene expression must then be translated
into localized growth at the synapse. Activated Wal-
lenda at the synapse is an attractive candidate to inte-
grate changes in gene expression with regulation of
the synaptic cytoskeleton to control synaptic growth.
Experimental Procedures
Suppressor Screen
Isogenic males carrying the homozygous EP(3)0381 transgene (con-
taining the UAS promoter upstream of fat facets) were fed a solution
of 5% sucrose and 22 mM methanesulfonic acid ethyl ester (EMS)(Sigma, St. Louis, MO) for 12–16 hr. These males were mated to
hiw1;elav-Gal4 virgin females. The F1 progeny of 600 independent
crosses (corresponding to at least 20,000 mutagenized chromo-
somes) were screened for the presence of living adult males. Of
the eighteen mutants found, sixteen failed to complement the reces-
sive eye phenotype of fafBx4 (Fischer-Vize et al., 1992), indicating
that they are alleles of faf. The other two suppressors are alleles of
wallenda (wnd1 and wnd2). The third wallenda allele (wnd3) was
found in the strain background of hiwPF253 as a modifier of the high-
wire synaptic phenotype.
Mapping wallenda
The wallenda locus was mapped by meiotic recombination and de-
ficiency mapping to 76B4–76D5. The map position was refined using
male recombination (Chen et al., 1998). Recombinants generated
with GS5186 and with l(3)L1243 narrowed the locus to a region of
20 kb at 76B9 that contains CG8789.
Transgenic Wallenda Constructs
A full-length cDNA for wallenda (CG8789) was obtained from Re-
search Genetics (Clone ID: LD14856). The entire 4.3 kb cDNA frag-
ment was subcloned into pUAST to generate the UAS-wnd trans-
gene. To generate UAS-wndKD, a conserved lysine in the kinase
domain, K188, was changed to Ala using the Gene Editor in vitro
Site-Directed Mutagenesis System (Promega, Madison, WI). Trans-
formant lines were generated using standard techniques. Expres-
sion of UAS-wnd using the elav-Gal4 driver causes embryonic lethal-
ity. wallenda gain-of-function phenotypes were characterized using
the panneuronal BG380-Gal4 driver (for Figures 6 and 7) and
DVGLUT-Gal4 (for Figure 5), which drives expression in motoneu-
rons (R. Daniels and A.D., unpublished data).
Fly Stocks
The following strains were used in this study: Canton S (wild-type),
BG380Gal4 (neuron specific; Budnik et al., 1996), elav-Gal4 (neuron
specific; Yao and White, 1994), DVGLUT-Gal4 (R. Daniels and A.D.,
unpublished data), MHC-Gal4 and G7-Gal4 (Zhang et al., 2001; mus-
cle specific), EP(3)0381 (Rorth et al., 1998), UAS-BskDN (Weber et al.,
2000), UAS-p38bDN (Adachi-Yamada et al., 1999), Dp38a (Craig
et al., 2004), UAS-FosDN (Fbz) and UAS-FosDN (Jbz) (Eresh et al.,
1997), witA12 and witB11 (Harrison et al., 1995), witHA3 (Aberle et al.,
2002), Df(3L)C175 (Kulkarni et al., 1994), UAS-activated Tkv (2D2)
(Hoodless et al., 1996), hiwDN (Wu et al., 2005), and hiw alleles
from (Wan et al., 2000): hiwPF253, hiw1, and hiwND8.
Antisera to Wallenda
The rabbit a-Wallenda polyclonal antibody WndA1 was raised
against a peptide corresponding to residues 798–811 in Wallenda
gene product (–HSKRRKHPLGDNPN) by Zymed (San Francisco,
CA). Antisera were affinity purified and used at a 1:100 dilution for
immunocytochemistry.
Western Blots
Whole-cell extracts from dissected larval brains and ventral nerve
cords were prepared as previously described (Wu et al., 2005) and
run on 7% SDS-PAGE gels. Western blots were probed with
WndA1 (1:100) or b-tubulin (1:1000) in PBS buffer containing 5%
dry milk and 0.1% Tween-20.
Immunocytochemistry
To detect endogenous Wallenda, wandering third-instar larvae were
dissected in ice-cold PBS and fixed in a PBS solution containing
3.7% formaldehyde for 1 to 1.5 hr on ice. Blocking and staining
was performed in PBS containing 0.1% Triton-X. To reduce back-
ground staining, WndA1 antisera were preincubated with fixed em-
bryos for >1 day at 4ºC and reused. For phospho-MAD staining, lar-
vae were fixed in formaldehyde. For all other antibodies, larvae were
fixed in Bouin’s solution (a 1:5:15 ratio of acetic acid/formalin/picric
acid) for 15 min. Other antibodies were used at the following dilu-
tions: rabbit a-DVGLUT (Daniels et al., 2004) at 1:10,000, rabbit
a-Syt (Mackler et al., 2002) at 1:5000, mouse monoclonal NC82
(Wagh et al., 2006) at 1:100, rabbit a-phospho-MAD (Tanimoto
et al., 2000) at 1:5000, and mouse monoclonal BP102 (generated
by Corey Goodman and obtained from the Developmental Studies
Neuron
68Hybridoma bank) at 1:10. Cy3-conjugated goat a-HRP (Jackson
Immunoresearch, West Grove, PA), and Cy3 488 (Jackson Immunor-
esarch) and Alexa 488 (from Molecular Probes, Invitrogen) conju-
gated a-rabbit and a-mouse secondary antibodies were used at
1:1000.
Imaging and Analysis
Images were acquired on a Nikon (Tokyo, Japan) C1 confocal micro-
scope. Samples for each experiment were processed simulta-
neously with a wild-type control and imaged using the same confo-
cal gain settings. All quantifications were performed while blinded
to genotype. The muscle sizes for all larvae analyzed were similar.
MetaMorph software (Molecular Devices, Sunnyvale, CA) was
used for analysis of bouton size and synaptic area, and DVGLUT,
Syt, and phospho-MAD intensity. Bouton size was determined by
measuring the area of DVGLUT staining. Synaptic area was deter-
mined by measuring the area of continuous HRP staining that con-
tained boutons so as to exclude nonsynaptic axonal HRP. The inten-
sity of DVGLUT staining (or Syt staining) within this synaptic area
was used to determine the average intensity of synaptic vesicle
markers. We also measured the total intensity of DVGLUT in these
images and observed a similar trend amongst genotypes to the
average intensity. Statistical analysis was performed and graphs
were generated using Origin 7.0 (Origin Lab, Northampton, MA).
Each sample was compared with other samples in the group using
ANOVA.
Electrophysiology
Electrophysiological recordings were performed as previously de-
scribed (Marrus and DiAntonio, 2004; Marrus et al., 2004). Spontane-
ous mEJPs and evoked EJPs were recorded in 0.45 mM Ca2+ Stew-
art saline (HL-3) (Stewart et al., 1994). At least 60 consecutive
spontaneous events were measured per cell using MiniAnal (Synap-
tosoft, Decatur, GA) and averaged to determine the mean mEJP.
Quantal content was estimated by dividing the mean EJP by the
mean mEJP. For all genotypes, the mean resting potentials and
input resistances were similar, with average resting potentials of
271 +/23 mV and input resistances of 5.5 6 0.3 MU.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/51/1/57/DC1/.
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